The Latest Headlines at American Banking and Market News
HubSpot (NYSE:HUBS) PT Lowered to $655.00
HubSpot (NYSE:HUBS – Free Report) had its price target lowered by Piper Sandler from $675.00 to $655.00 in a research note published on Thursday, Benzinga reports. The firm currently has an overweight rating on the software maker’s... More of this article »
Evercore ISI Reaffirms “In-Line” Rating for Truist Financial (NYSE:TFC)
Evercore ISI reissued their in-line rating on shares of Truist Financial (NYSE:TFC – Free Report) in a report released on Thursday, MarketBeat Ratings reports. Evercore ISI currently has a $44.00 price target on the insurance... More of this article »
International Money Express (NASDAQ:IMXI) Stock Rating Reaffirmed by Needham & Company LLC
Needham & Company LLC restated their buy rating on shares of International Money Express (NASDAQ:IMXI – Free Report) in a research report report published on Thursday, Benzinga reports. They currently have a $25.00 price... More of this article »
Wedbush Equities Analysts Decrease Earnings Estimates for AMC Entertainment Holdings, Inc. (NYSE:AMC)
AMC Entertainment Holdings, Inc. (NYSE:AMC – Free Report) – Stock analysts at Wedbush cut their Q2 2024 earnings per share estimates for AMC Entertainment in a report released on Thursday, May 9th. Wedbush analyst A.... More of this article »
Perion Network (NASDAQ:PERI) Rating Reiterated by Needham & Company LLC
Needham & Company LLC reissued their buy rating on shares of Perion Network (NASDAQ:PERI – Free Report) in a research report sent to investors on Thursday, Benzinga reports. Needham & Company LLC currently has a $18.00... More of this article »
Radware (NASDAQ:RDWR) Given Hold Rating at Needham & Company LLC
Needham & Company LLC reiterated their hold rating on shares of Radware (NASDAQ:RDWR – Free Report) in a research report released on Thursday morning, Benzinga reports. Several other equities research analysts have also... More of this article »
Wedbush Reiterates “Outperform” Rating for Arcus Biosciences (NYSE:RCUS)
Wedbush reissued their outperform rating on shares of Arcus Biosciences (NYSE:RCUS – Free Report) in a research report released on Thursday, Benzinga reports. The firm currently has a $30.00 price target on the stock. Wedbush... More of this article »
Toast (NYSE:TOST) PT Raised to $25.00
Toast (NYSE:TOST – Free Report) had its price target lifted by Piper Sandler from $20.00 to $25.00 in a research report report published on Thursday morning, Benzinga reports. The brokerage currently has a neutral rating on the... More of this article »
The Goldman Sachs Group Lowers Match Group (NASDAQ:MTCH) Price Target to $37.00
Match Group (NASDAQ:MTCH – Free Report) had its price target trimmed by The Goldman Sachs Group from $47.00 to $37.00 in a report released on Thursday, Benzinga reports. The firm currently has a buy rating on the technology company’s... More of this article »
Confluent (NASDAQ:CFLT) Price Target Increased to $30.00 by Analysts at The Goldman Sachs Group
Confluent (NASDAQ:CFLT – Free Report) had its target price lifted by The Goldman Sachs Group from $27.00 to $30.00 in a report released on Thursday morning, Benzinga reports. They currently have a neutral rating on the stock. CFLT... More of this article »
The Goldman Sachs Group Trims Intel (NASDAQ:INTC) Target Price to $30.00
Intel (NASDAQ:INTC – Free Report) had its price target cut by The Goldman Sachs Group from $34.00 to $30.00 in a research report report published on Thursday morning, Benzinga reports. They currently have a sell rating on the... More of this article »
Nextdoor (NYSE:KIND) PT Raised to $2.50
Nextdoor (NYSE:KIND – Free Report) had its price objective increased by The Goldman Sachs Group from $2.25 to $2.50 in a research note published on Thursday, Benzinga reports. The Goldman Sachs Group currently has a neutral rating... More of this article »
IGM Biosciences (NASDAQ:IGMS) Rating Reiterated by Wedbush
Wedbush reiterated their outperform rating on shares of IGM Biosciences (NASDAQ:IGMS – Free Report) in a research note published on Thursday morning, MarketBeat.com reports. Wedbush currently has a $20.00 price objective on... More of this article »